Breaking News Instant updates and real-time market news.

ARRY

Array BioPharma

$14.65

-0.15 (-1.01%)

08:01
08/14/18
08/14
08:01
08/14/18
08:01

Array BioPharma reports Q4 EPS (25c), consensus (24c)

Reports Q4 revenue $35.4M, consensus $38.73M.

  • 14

    Aug

ARRY Array BioPharma
$14.65

-0.15 (-1.01%)

06/20/18
CANT
06/20/18
NO CHANGE
Target $24
CANT
Overweight
Array BioPharma shares could have more room to advance, says Cantor Fitzgerald
Cantor Fitzgerald analyst Mara Goldstein believes Array BioPharma's combination of binimetinib/encorafenib has the "potential to be best-in-class and take a market-leader position." The FDA action date is June 30. Further, the analyst sees opportunity in BRAF+ CRC based on the safety lead-in portion of the Beacon study, which she believes could expand the potential market, with updated results to be presented on June 23. Goldstein thinks Array shares "could have further room to advance" and keeps an Overweight rating on the name with a $24 price target.
06/25/18
PIPR
06/25/18
NO CHANGE
Target $21
PIPR
Overweight
Piper backs Overweight on Array BioPharma after 'impressive' BEACON update
Piper Jaffray analyst Edward Tenthoff reiterated an Overweight rating and $21 price target on Array BioPharma after the company reported an "impressive" one-year overall survival rate of 62% from the safety lead-in of the Phase 3 BEACON CRC trial evaluating the triplet combination of encorafenib, a BRAF inhibitor, binimetinib, a MEK inhibitor and cetuximab, an anti-EGFR antibody, in patients with BRAFV600E-mutant metastatic colorectal cancer. In a research note to investors, Tenthoff also said he is confident in the approval of Braftovi + Mektovi in BRAF-mutant melanoma by the June 30 PDUFA date.
06/25/18
RHCO
06/25/18
NO CHANGE
Target $25
RHCO
Buy
Array BioPharma price target raised to $25 from $19 at SunTrust
SunTrust analyst Peter Lawson raised his price target on Array BioPharma to $25 after the company's updated data from the lead in portion of the Phase 3 BEACON CRC trial of bini/enco/cetuximab. Lawson notes that Array offered survival data for the first time, and that the 12-month OS was "far better" than with SOC regimens at less than 6 months. The analyst believes the findings are "encouraging", increasing his probability of success and market penetration estimates for BEACON CRC while keeping his Buy rating on Array BioPharma.
06/27/18
PIPR
06/27/18
NO CHANGE
Target $25
PIPR
Overweight
Piper ups Array BioPharma price target to $25 after early BRAF-melanoma approval
Piper Jaffray analyst Edward Tenthoff said he is encouraged by the early approval of Array Biopharma's Braftovi and Mektovi combination in BRAF-mutant melanoma ahead of the June 30 PDUFA date and he believes the label "looks good." Tenthoff, who thinks the improved tolerability and "best in class" efficacy of the combination will support rapid uptake, raised his price target on Array shares to $25 from $21 following the approval announcement and he keeps an Overweight rating on the stock.

TODAY'S FREE FLY STORIES

HST

Host Hotels

$17.31

-0.46 (-2.59%)

06:21
12/18/18
12/18
06:21
12/18/18
06:21
Upgrade
Host Hotels rating change  »

Host Hotels upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PSA

Public Storage

$199.42

-4.07 (-2.00%)

06:20
12/18/18
12/18
06:20
12/18/18
06:20
Upgrade
Public Storage rating change  »

Public Storage upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CUBE

CubeSmart

$30.16

-1.22 (-3.89%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
CubeSmart rating change  »

CubeSmart downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INVH

Invitation Homes

$20.75

-0.62 (-2.90%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
Invitation Homes rating change  »

Invitation Homes…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LSI

Life Storage

$98.10

-3.19 (-3.15%)

06:19
12/18/18
12/18
06:19
12/18/18
06:19
Downgrade
Life Storage rating change  »

Life Storage downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LGF.A

Lionsgate

$15.06

-0.53 (-3.40%)

, LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

06:16
12/18/18
12/18
06:16
12/18/18
06:16
Upgrade
Lionsgate, Use LGF.A, LGF.B, Lionsgate rating change  »

Lionsgate upgraded to Buy…

LGF.A

Lionsgate

$15.06

-0.53 (-3.40%)

LGF

Use LGF.A, LGF.B

$0.00

(0.00%)

LGF.B

Lionsgate

$14.01

-0.48 (-3.31%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Hot Stocks
Elanco CEO says 'well positioned to grow top line revenue' »

"Our financial…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

CS

Credit Suisse

$10.94

-0.155 (-1.40%)

06:14
12/18/18
12/18
06:14
12/18/18
06:14
Periodicals
Credit Suisse advises clients to mull shifting assets out of UK, FT reports »

Private bankers at Credit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Jan

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Earnings
Elanco sees FY19 adjusted EPS $1.02-$1.12 »

Sees FY19 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

ORCL

Oracle

$45.72

-0.9 (-1.93%)

06:12
12/18/18
12/18
06:12
12/18/18
06:12
Recommendations
Oracle analyst commentary  »

Oracle posted 'solid…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDWR

Radware

$22.62

-0.17 (-0.75%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Hot Stocks
Radware announces deal with financial information technology provider »

Radware announced a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ATGE

Adtalem Global Education

$50.01

-1.14 (-2.23%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Recommendations
Adtalem Global Education analyst commentary  »

Adtalem called a top…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LMT

Lockheed Martin

$279.17

-8.54 (-2.97%)

06:08
12/18/18
12/18
06:08
12/18/18
06:08
Periodicals
Japan to purchase 100 additional F-35 stealth fighters, FT reports »

Japan has said it will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ELAN

Elanco

$31.76

-0.63 (-1.95%)

06:06
12/18/18
12/18
06:06
12/18/18
06:06
Earnings
Elanco reaffirms FY18 adjusted EPS view $1.14-$1.16, consensus $1.21 »

Reaffirms FY18 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

HTGC

Hercules Capital

$10.83

-0.53 (-4.67%)

06:05
12/18/18
12/18
06:05
12/18/18
06:05
Hot Stocks
Hercules Capital announces $25M share repurchase program »

Hercules Capital…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:03
12/18/18
12/18
06:03
12/18/18
06:03
Hot Stocks
Luxfer to acquire Neo Performance Materials for $612M in cash and stock »

Luxfer Holdings and Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
J&J CEO Alex Gorsky: 'We know our talc is safe,' 'does not cause cancer' »

Johnson & Johnson CEO…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

TPC

Tutor Perini

$16.63

-0.08 (-0.48%)

06:02
12/18/18
12/18
06:02
12/18/18
06:02
Hot Stocks
Tutor Perini subsidiary awarded $104M contract by Royal Saudi Air Force »

Tutor Perini announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPA

Copa Holdings

$75.17

-2.54 (-3.27%)

06:01
12/18/18
12/18
06:01
12/18/18
06:01
Initiation
Copa Holdings initiated  »

Copa Holdings reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LXFR

Luxfer

$21.42

-1.26 (-5.56%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Hot Stocks
Breaking Hot Stocks news story on Luxfer »

Luxfer to acquire Neo…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGRO

Adecogro

$6.69

-0.35 (-4.97%)

06:00
12/18/18
12/18
06:00
12/18/18
06:00
Initiation
Adecogro initiated  »

Adecogro initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TSLA

Tesla

$348.30

-17.39 (-4.76%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
Musk's Boring Co. faces concerns over diversion of SpaceX resources, WSJ says »

Elon Musk's the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNJ

Johnson & Johnson

$129.11

-3.75 (-2.82%)

05:59
12/18/18
12/18
05:59
12/18/18
05:59
Periodicals
J&J looks to contain fallout from baby powder report with ads, Reuters reports »

Johnson & Johnson on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jan

  • 27

    Jan

EFX

Equifax

$97.25

0.06 (0.06%)

05:55
12/18/18
12/18
05:55
12/18/18
05:55
Conference/Events
Equifax to meet with investors »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Dec

UNCFF

UniCredit

$0.00

(0.00%)

05:53
12/18/18
12/18
05:53
12/18/18
05:53
Hot Stocks
Italy's UniCredit settles dispute with Caius »

On August 6, UniCredit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.